{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:39:59Z","timestamp":1760060399282,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and Training Project","award":["B2023-TNA-03"],"award-info":[{"award-number":["B2023-TNA-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The HLA-B*58:01 allele is strongly linked to severe cutaneous adverse reactions (SCARs) during allopurinol treatment, and it has been associated with the A allele of PSORS1C1 rs9263726 (G&gt;A). Paraclinical characteristics of gout are indicative of associated comorbid conditions. This study investigated the genotype frequency of HLA-B*58:01 and its association with paraclinical characteristics and PSORS1C1 rs9263726 in gout patients from Northeast Vietnam. Methods: A total of 133 unrelated gout patients were randomly recruited by the clinician. BioEdit sequence alignment editor version 7.2.5 software (Raleigh, Raleigh, NC, USA) was used for the analysis of nucleotide sequence data of HLA-B gene alleles from the IPD-IMGT\/HLA Database, which showed that the HLA-B*58:01 allele can be distinguished from reference and other alleles by specific nucleotide positions: 387C, 379C, 368A, 355A, and 353T (in exon 3); and 319C, 285G, and 209A (in exon 2). HLA-B*58:01 and PSORS1C1 rs9263726 genotypes were identified using Sanger sequencing of PCR products, analyzed with BioEdit software, and verified using the NCBI dbVar database. Statistical analyses were performed using SPSS version 25.0. Results: Our study revealed a significant age difference between male and female gout patients (p &lt; 0.001). Male gout patients had an average age of 51.44 \u00b1 14.59 years, whereas female gout patients were notably older, with an average age of 70.33 \u00b1 10.64 years. Positive correlations were observed between platelet count, serum creatinine, and uric acid levels (r = 0.174, p = 0.045; r = 0.195, p = 0.025) in male gout patients, while only high-density lipoprotein cholesterol showed a statistically significant negative correlation with uric acid levels (r = \u22120.885, p = 0.002) in female patients. The HLA-B*58:01 allele frequency among study subjects was 6.02%, with 12.03% being heterozygous individuals (*X\/HLA-B*58:01, N = 16). The HLA-B*58:01 allele was not detected in female gout patients. White blood cell counts were significantly higher in male gout patients with the *X\/HLA-B*58:01 genotype compared to those with the *X\/*X genotype (p = 0.018). The A allele frequency of PSORS1C1 rs9263726 was 7.89%, and the heterozygous mutant genotype PSORS1C1 GA had a frequency of 15.79% (N = 21). Among the *X\/*58:01 carriers, 4.51% had the GG genotype, and 7.52% had the GA genotype at PSORS1C1 rs9263726. Conclusions: Our study showed that the HLA-B*58:01 allele was not detected in female gout patients. White blood cell counts differed significantly between the *X\/HLA-B*58:01 and *X\/*X groups in male gout patients. The A allele of PSORS1C1 rs9263726 was not consistently associated with HLA-B*58:01 and was not a reliable marker for its detection in this study population.<\/jats:p>","DOI":"10.3390\/diagnostics15162114","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:46:04Z","timestamp":1755787564000},"page":"2114","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype Frequency of HLA-B*58:01 and Its Association with Paraclinical Characteristics and PSORS1C1 rs9263726 in Gout Patients"],"prefix":"10.3390","volume":"15","author":[{"given":"Hien Thu","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Foundation Medicine, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Thi","family":"Bui","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Foundation Medicine, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Thi Thu","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Natural Science and Technology, Thai Nguyen University of Sciences, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"My Ha","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Natural Science and Technology, Thai Nguyen University of Sciences, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manh Duc","family":"Ngo","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Natural Science and Technology, Thai Nguyen University of Sciences, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Hoang","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Deparment of Biology, Thai Nguyen Specialized School, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy Thi Thanh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Deparment of Biology, Thai Nguyen Specialized School, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhuan Tien","family":"Ngo","sequence":"additional","affiliation":[{"name":"Outpatient Department, Thai Nguyen National Hospital, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang Viet","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Occupational Health and Environmental Health, Faculty of Public Health, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen University, Thai Nguyen 250000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Asghari, K.M., Zahmatyar, M., Seyedi, F., Motamedi, A., Zolfi, M., Alamdary, S.J., Fazlollahi, A., Shamekh, A., Mousavi, S.E., and Nejadghaderi, S.A. (2024). Gout: Global epidemiology, risk factors, comorbidities and complications: A narrative review. BMC Musculoskelet. Disord., 25.","DOI":"10.1186\/s12891-024-08180-9"},{"key":"ref_2","unstructured":"Pratt, V.M., Pirmohamed, M., Esquivel, B., Kane, M.S., Kattman, B.L., and Malheiro, A.J. (2019). Lesinurad Therapy and CYP2C9 genotype. Medical Genetics Summaries, National Center for Biotechnology Information."},{"key":"ref_3","unstructured":"Pratt, V.M., Pirmohamed, M., Esquivel, B., Kane, M.S., Kattman, B.L., and Malheiro, A.J. (2020). Pegloticase therapy and G6PD genotype. Medical Genetics Summaries, National Center for Biotechnology Information."},{"key":"ref_4","unstructured":"Pratt, V.M., Pirmohamed, M., Esquivel, B., Kane, M.S., Kattman, B.L., and Malheiro, A.J. (2020). Allopurinol therapy and HLA-B*58:01 genotype. Medical Genetics Summaries, National Center for Biotechnology Information."},{"key":"ref_5","unstructured":"Pratt, V.M., Pirmohamed, M., Esquivel, B., Kane, M.S., Kattman, B.L., and Malheiro, A.J. (2021). Celecoxib therapy and CYP2C9 genotype. Medical Genetics Summaries, National Center for Biotechnology Information."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/cclm-2014-0251","article-title":"Detection of HLA-B*58: 01 with TaqMan assay and its association with allopurinol-induced sCADR","volume":"53","author":"Zhang","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*58:01 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*58:01 and allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Jantararoungtong","year":"2009","journal-title":"Pharmacogenet. Genom."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A whole-genome association study of major determinants for allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Tohkin","year":"2013","journal-title":"Pharmacogenom. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet. Genom."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FPC.0000000000000408","article-title":"HLA-B* 58: 01 association in allopurinol-induced severe cutaneous adverse reactions: The implication of ethnicity and clinical phenotypes in multiethnic Malaysia","volume":"30","author":"Low","year":"2020","journal-title":"Pharmacogenet. Genom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.31128\/AJGP-12-21-6264","article-title":"Allopurinol for gout: Consider the case for limited HLA-B*58:01 screening","volume":"51","author":"Tse","year":"2022","journal-title":"Aust. J. Gen. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0039.2007.00982.x","article-title":"HLA-A, -B, -C, -DRB1 and-DQB1 alleles and haplotypes in the Kinh population in Vietnam","volume":"71","author":"Hoa","year":"2008","journal-title":"Tissue Antigens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.waojou.2019.100037","article-title":"Developing pharmacogenetic screening methods for an emergent country: Vietnam","volume":"12","author":"Nguyen","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/pgs.15.41","article-title":"Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups","volume":"16","author":"He","year":"2015","journal-title":"Pharmacogenomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.dmpk.2015.08.007","article-title":"A polymorphism within the psoriasis susceptibility 1 candidate 1 (PSORS1C1) gene is not linked to HLA-B*58:01 in an Australian cohort","volume":"31","author":"Vidal","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2738784","DOI":"10.1155\/2017\/2738784","article-title":"Comparison between the HLA-B*58:01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions","volume":"2017","author":"Saksit","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/pme.15.38","article-title":"rs9263726 is a specific genetic marker for allopurinol-induced severe cutaneous adverse reactions in Chinese patients","volume":"12","author":"Chen","year":"2015","journal-title":"J. Pers. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.dmpk.2018.08.001","article-title":"HLA-B*58: 01 and rs9263726 have a linkage, but not absolute linkage disequilibrium in Han Chinese population","volume":"33","author":"Dou","year":"2018","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Takeshita","year":"2015","journal-title":"J. Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/pgs-2020-0014","article-title":"Gene expression profiling in allopurinol-induced severe cutaneous adverse reactions in Vietnamese","volume":"21","author":"Nguyen","year":"2020","journal-title":"Pharmacogenomics"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Singh, J.A., and Gaffo, A. (2020). Gout epidemiology and comorbidities. Seminars in Arthritis and Rheumatism, Elsevier.","DOI":"10.1016\/j.semarthrit.2020.04.008"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Timsans, J., Palom\u00e4ki, A., and Kauppi, M. (2024). Gout and hyperuricemia: A narrative review of their comorbidities and clinical implications. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247616"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD","volume":"61","author":"Jalal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/tan.14078","article-title":"Human leukocyte antigen associations with renal function among ethnic minorities in the United Kingdom","volume":"96","author":"Lowe","year":"2020","journal-title":"HLA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Malekmohammad, K., Bezsonov, E.E., and Rafieian-Kopaei, M. (2021). Role of lipid accumulation and inflammation in atherosclerosis: Focus on molecular and cellular mechanisms. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.707529"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.18585\/inabj.v14i3.1892","article-title":"Increased Platelet-derived Microparticles Counts is Correlated with Elevated Blood LDL Cholesterol in Acute Myocardial Infarction","volume":"14","author":"Supriami","year":"2022","journal-title":"Indones. Biomed. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1093\/rheumatology\/keq274","article-title":"Body composition and metabolic syndrome in patients with primary gout in Vietnam","volume":"49","author":"Dao","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.humimm.2009.05.006","article-title":"Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population","volume":"70","author":"Keicho","year":"2009","journal-title":"Hum. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Duc, D.M., Hoang, L.L.G., Nguyen, V.T., Dang, T.N., Nguyen, N.H., Vu, H.A., and Mai, T.P. (2020). High-Resolution HLA Typing of HLA-A, -B, -C, -DRB1, and -DQB1 in Kinh Vietnamese by Using Next-Generation Sequencing. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00383"},{"key":"ref_32","first-page":"759","article-title":"Cirrhosis: Diagnosis and management","volume":"100","author":"Smith","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.31557\/APJCP.2023.24.6.2073","article-title":"Association of ADH1B rs1229984, ADH1C rs698, and ALDH2 rs671 with Alcohol abuse and Alcoholic Cirrhosis in People Living in Northeast Vietnam","volume":"24","author":"Hoang","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.31557\/APJCP.2022.23.12.4243","article-title":"Single nucleotide polymorphisms of ADH1B, ADH1C and ALDH2 genes in 235 people living in thai nguyen province of Vietnam","volume":"23","author":"Hoang","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_35","first-page":"94","article-title":"The nutritional practice of gout patients at Duc Giang general hopital, in 2020","volume":"531","author":"Thuong","year":"2023","journal-title":"Vietnam. Med. J."},{"key":"ref_36","first-page":"72","article-title":"Clinical manifastations and laboratory charactoristics of gout and some related factor at Nge An general friendship hospital","volume":"544","author":"Thuy","year":"2024","journal-title":"Vietnam. Med. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021","volume":"6","author":"Cross","year":"2024","journal-title":"J. Lancet Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: Prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"J. Nat. Rev. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s42358-019-0067-7","article-title":"Gender-specific risk factors for gout: A systematic review of cohort studies","volume":"59","author":"Evans","year":"2019","journal-title":"J. Adv. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: A prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"J. Lancet Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjmed.2013.12.019","article-title":"Alcohol quantity and type on risk of recurrent gout attacks: An internet-based case-crossover study","volume":"127","author":"Neogi","year":"2014","journal-title":"J Am. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"J. Circ."},{"key":"ref_44","unstructured":"Luu, N.B., and Nguyen, T.T. (2018). Consumption of Alcohol Beverages in Viet Nam\u2014Some National Investigation Results, National Economics University Publishing Company."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/biof.1453","article-title":"Relationship between platelet count and platelet width distribution and serum uric acid concentrations in patients with untreated essential hypertension","volume":"44","author":"Tayefi","year":"2018","journal-title":"J. BioFactors"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ard.51.1.101","article-title":"Relation between creatinine and uric acid excretion","volume":"51","author":"Nishida","year":"1992","journal-title":"J. Ann. Rheum. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40200-021-00746-x","article-title":"Serum Uric acid is a better indicator of kidney impairment than serum uric acid to creatine ratio; a cross sectional study of type 2 diabetes mellitus patients","volume":"20","author":"Ephraim","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18585\/inabj.v1i1.83","article-title":"The Correlations Between Concentrations of Myeloperoxidase, Serum Amyloid-A Protein and Scretory Phospolipase A-2 with Proinflammatory HDL in Healthy Male Person","volume":"1","author":"Kaniawati","year":"2009","journal-title":"Indones. Biomed. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/meta.2003.50072","article-title":"Plasma C-reactive protein in subjects with hypo\/hyperalphalipoproteinemias","volume":"52","author":"Pirro","year":"2003","journal-title":"Metabolism"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jung, E., Kong, S.Y., Ro, Y.S., Ryu, H.H., and Shin, S.D. (2022). Serum cholesterol levels and risk of cardiovascular death: A systematic review and a dose-response meta-analysis of prospective cohort studies. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19148272"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhao, X., Wang, D., and Qin, L. (2021). Lipid profile and prognosis in patients with coronary heart disease: A meta-analysis of prospective cohort studies. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-020-01835-0"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1590\/1678-4685-gmb-2017-0258","article-title":"Clinical evaluation of a substitute of HLA-B* 58: 01 in different Chinese ethnic groups","volume":"41","author":"Zhang","year":"2018","journal-title":"J. Genet. Mol. Biol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/16\/2114\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:09Z","timestamp":1760034789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/16\/2114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":52,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["diagnostics15162114"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15162114","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}